SOURCE: AirWare Labs

AirWare Labs

October 28, 2014 08:00 ET

AirWare Labs Launches Revolutionary New Skin Care Line to Treat Wrinkles, Acne, Scars and Warts

Company Enters $122 Billion Global Skin Care and Cosmetic Market With Its Patented Anti-Aging Products, Set for National Rollout in Early 2015

SCOTTSDALE, AZ--(Marketwired - Oct 28, 2014) - AirWare Labs Corp. (OTCQB: AIRW) today announced it has launched a line of skin care products that utilize pharmaceutical-grade serums in a patented treatment system designed to enhance and provide youthful benefits to the skin.

"We are excited to expand into skin care with this line of products," said Jeffrey Rassás, CEO of AirWare Labs. "There is enormous demand for effective treatments for lines and wrinkles, acne and other common skin conditions, and we've developed a unique patented system that generates tremendous results."

The first product in the skin care line, which will be available for purchase in early 2015, employs a high-grade vitamin C serum combined with a patented protective shield to target facial wrinkles including crow's feet, frown and lip lines as well as wrinkles affecting the décolleté and chest areas. The serum boosts collagen production in the skin to fill wrinkles and lines, while the shield works to prevent oxidation of the serum and keeps the skin smooth overnight.

"Oxidation is the biggest enemy of any topical skin care product," said Dan Pool, Vice President of Product Development at AirWare Labs. "As soon as a serum or cream is exposed to the air, it begins to break down and lose potency. Our patented dermal shield acts as a barrier to this damaging oxidation and allows our serum to retain its effectiveness overnight, greatly enhancing the anti-aging benefits."

With the national rollout of the anti-aging product, AirWare Labs will be entering a $122.3 billion global market, driven by the baby boomer generation, which is expected to reach $191.7 billion by 2019, according to a recent report by Transparency Market Research.

"This new line is the next step in our mission to promote better health and well being through technologically innovative products," said Rassás. "Under Dan Pool's leadership, our product development team has created a skin care system that will be highly competitive in the marketplace."

Following the anti-wrinkle product, AirWare will roll out skin care systems to treat acne, scars and warts -- all using proprietary pharmaceutical-grade serums combined with patented dermal shields. All of the products will be made available to the public through a network of national distribution partners.

About AirWare Labs Corporation:

AirWare Labs Corp. [publicly traded as (OTCQB: AIRW)] provides patented and innovative technology solutions for consumer products that promote better health and enhanced wellbeing. AirWare Labs' breathing products are marketed under the brand name of AIR®. AIR® products utilize an FDA approved medical grade material, molded as an intranasal Air Breathe dilator, to act as the delivery system. This AIR® microstructure enhances normal nasal airflow with every breath -- clinically proven to deliver up to 40% more oxygen. 

Some AIR® products are infused with essential oils with unique healing properties including antibacterial and therapeutic defense against airborne allergens, viruses and bacteria. AIR® Allergy and Travel products provide additional defense in the form of an integrated filter media from 3M to remove microscopic particles that carry viruses, allergens and bacteria. Other AIR® specialty products help provide performance enhancements and relief from congestion, insomnia, headaches, nausea, and snoring. For more product information, please visit: http://www.airwarelabs.com or company information visit: http://airwarelabscorp.com.

Forward-Looking Statement: The statements in this press release regarding any implied or perceived benefits from the release by AirWare Labs Corp. of its products are forward-looking statements. Such statements involve risks and uncertainties, including, but not limited to, risks and effects of legal and administrative proceedings and governmental regulation, especially in a foreign country, future financial and operational results, competition, general economic conditions, and the ability to manage and continue growth.

Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes may vary materially from those indicated. Important factors that could cause actual results to differ materially from the forward-looking statements we make in this news release include the introduction of new technology, market conditions and those set forth in reports or documents we file from time to time with the SEC. We undertake no obligation to revise or update such statements to reflect current events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Contact Information

  • Media Contact:
    Jennifer Breitegan
    jen@kwprgroup.com

    Investor Relations:
    Keith Pinder
    Acorn Management
    678-736-5682